Medtronic Adjusts Long-Term Goals (MDT)
Medical devices was supposed to be recession-proof, or at least was supposed to be recession-resistant. But we have seen over and over how this notion has not been the case. Medtronic Inc. (NYSE: MDT) today highlighted further evidence that medical…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Medical devices was supposed to be recession-proof, or at least was supposed to be recession-resistant. But we have seen over and over how this notion has not been the case. Medtronic Inc. (NYSE: MDT) today highlighted further evidence that medical technology has to adjust to a new, harsher environment.
The company was presenting data at the J.P. Morgan health careconference and it brought down some of its longer-term forecasts. Itblamed a sluggish market for new implantable defibrillators, but theeconomy is the likely culprit here.
The company still expects earnings growth in the double-digits andit reaffirmed earnings targets for the fiscal April-2009 period.
Medtronic’s prior long-term sales growth over the next five years was 9% to 11%. The company now sees sales growing 5% to 8% for near-term, but put its long-term earningsgrowth target at 10% or more. Its prior growth target was roughly 11%to 14%.
This comes on the heels of its announcement that it plans to purchaseAblation Frontiers for an initial payment of $225 million pluspotential initial payments. With a $36 billion market cap, thatacquisition will hardly be noticed any time soon.
Jon C. Ogg
January 12, 2009
Contact [email protected] for any questions or corrections.




